Affiliation: University of Rochester
- DPP-4 inhibitors: what may be the clinical differentiators?John Gerich
University of Rochester School of Medicine, Rochester, NY 14642, USA
Diabetes Res Clin Pract 90:131-40. 2010..This review offers an overview of DPP-4 inhibitors in T2DM and suggests some characteristics that may provide clinically relevant differentiators within this class...
- Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humansChristian Meyer
Department of Medicine, University of Roichester School of Medicine, Rochester, NY 14642, USA
Am J Physiol Endocrinol Metab 285:E819-26. 2003....
- Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargineJohn Gerich
University of Rochester Medical Center, Rochester, New York, USA
Diabetes Technol Ther 8:237-43. 2006..This lower fluctuation of glargine over NPH or ultralente can help to reduce hyper- or hypoglycemia risks associated with insulin therapy and accordingly encourage achievement of better blood glucose control...
- Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearanceHans J Woerle
Department of Medicine, University of Rochester School of Medicine, Rochester, NY, USA
Metabolism 51:1494-500. 2002..04) and was similar to DM(-) (7.3 +/- 0.5 mL x kg(-1) x min(-1), P >.9). We conclude that in contrast to the excessive HGR, excessive RGR and impaired FFA clearance are not corrected by acute exogenous insulin replacement...